Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine.
about
Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Galiximab (anti-CD80)-induced ...... combination with fludarabine.
@en
Galiximab
@nl
type
label
Galiximab (anti-CD80)-induced ...... combination with fludarabine.
@en
Galiximab
@nl
prefLabel
Galiximab (anti-CD80)-induced ...... combination with fludarabine.
@en
Galiximab
@nl
P2093
P2860
P356
P1476
Galiximab (anti-CD80)-induced ...... combination with fludarabine.
@en
P2093
Arturo Molina
Benjamin Bonavida
Dana Clanton
Kandasamy Hariharan
Lisa Berquist
Mario I Vega
Steffan N Ho
Tracey Murphy
P2860
P304
P356
10.3892/IJO.2013.1986
P577
2013-06-13T00:00:00Z